Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • INVESTOR PORTAL 2025
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/

News From the Bluestem Team

November 29, 2021

Neurolens Wins "2021 EyeVote Reader's Choice Award"

November 29, 2021/ Michele Kleinwolterink

We’re pleased to share with you the announcement an announcement from Neurolens. The company has been awarded the EyeVote Reade'r’s Choice Award for Diagnostic Instruments Brand Introduced in 2021 (NMD2). See the Company’s post here on LinkedIn.

Shared by Steve Kirby, board member of Neurolens.

November 29, 2021/ Michele Kleinwolterink/

Michele Kleinwolterink

  • Virtual Incision Announces $46 ...
  • Lentechs Announces Preliminary ...

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.